[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Alternative Health Approaches, Dialysis Dimensions, EM Probe, and Washington Hos...[ Price : $8.95]
FDA approves BMS new chemotherapy drug Ixempra (ixabepilone) to treat advanced breast cancer in women whose tumors are resistant t...[ Price : $8.95]
CDER acting director Janet Woodcock confirms to the Associated Press that the agency will have a limited say in what direction the...[ Price : $8.95]
A New Jersey federal judge rejects FDA arguments defending its failure to adequately respond to three years of FOI requests from a...[ Price : $8.95]
Medi-Promotions launches its Medi-Scripts Plus prescription pad that included advertiser patient offers such as coupons and vouche...[ Price : $8.95]
FDA approves an expanded use for Millennium Pharmaceuticalss Velcade for treating multiple myeloma in patients with impaired kidne...[ Price : $8.95]
FDA extends by three months its review of an Elan and Biogen Idec BLA on Tysabri (natalizumab) as a treatment for Crohn's disease.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance on use of noinferiority studies to support approval of antibacterial drug p...